Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Aiko Iguchi"'
Publikováno v:
Veterinary Medicine and Science, Vol 9, Iss 3, Pp 1074-1077 (2023)
Abstract A 9‐year‐old castrated male Kaninchen dachshund dog weighing 4.18 kg was referred to our institution and presented with occasional vomiting and dysphagia. The radiographic examination revealed a long radiopaque foreign body located throu
Externí odkaz:
https://doaj.org/article/3bf1e81e1f0545e5a1fa22d7abe2ed84
Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo
Autor:
Shengwei Ji, Mingming Liu, Eloiza May Galon, Mohamed Abdo Rizk, Bumduuren Tuvshintulga, Jixu Li, Iqra Zafar, Yae Hasegawa, Aiko Iguchi, Naoaki Yokoyama, Xuenan Xuan
Publikováno v:
Parasites & Vectors, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Background Drug resistance and toxic side effects are major challenges in the treatment of babesiosis. As such, new drugs are needed to combat the emergence of drug resistance in Babesia parasites and to develop alternative treatment strateg
Externí odkaz:
https://doaj.org/article/3e93a3a18aa04b9b8a6d5a92c2581941
Autor:
Shengwei Ji, Onur Ceylan, Zhuowei Ma, Eloiza May Galon, Iqra Zafar, Hang Li, Yae Hasegawa, Mutlu Sevinc, Tatsunori Masatani, Aiko Iguchi, Osamu Kawase, Rika Umemiya-Shirafuji, Masahito Asada, Ferda Sevinc, Xuenan Xuan
Publikováno v:
Pathogens, Vol 11, Iss 5, p 500 (2022)
Diseases caused by tick-transmitted pathogens including bacteria, viruses, and protozoa are of veterinary and medical importance, especially in tropical and subtropical regions including Turkey. Hence, molecular surveillance of tick-borne diseases wi
Externí odkaz:
https://doaj.org/article/9278ff9bc1b8409d84a6dc279562aafd
Autor:
Paul Franck Adjou Moumouni, Gabriel Oluga Aboge, Mohamad Alaa Terkawi, Tatsunori Masatani, Shinuo Cao, Ketsarin Kamyingkird, Charoonluk Jirapattharasate, Mo Zhou, Guanbo Wang, Mingming Liu, Aiko Iguchi, Patrick Vudriko, Adrian Patalinghug Ybanez, Hisashi Inokuma, Rika Shirafuji-Umemiya, Hiroshi Suzuki, Xuenan Xuan
Publikováno v:
Parasites & Vectors, Vol 8, Iss 1, Pp 1-14 (2015)
Abstract Background Infections with Babesia bovis, Babesia bigemina, Theileria species and Anaplasma marginale are endemic in Kenya yet there is a lack of adequate information on their genotypes. This study established the genetic diversities of the
Externí odkaz:
https://doaj.org/article/3e515e0c4418404083f227a776794d74
Autor:
Shengwei Ji, Eloiza May Galon, Mohamed Abdo Rizk, Yunpeng Yi, Iqra Zafar, Hang Li, Zhuowei Ma, Aiko Iguchi, Masahito Asada, Mingming Liu, Xuenan Xuan
Publikováno v:
Antimicrob Agents Chemother
The present study aimed to evaluate the anti-Babesia effect of MMV390048, a drug that inhibits Plasmodium by targeting the phosphatidylinositol 4-kinase (PI4K). The half inhibitory concentration (IC(50)) of MMV390048 against the in vitro growth of Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac031fcdba3be123a82974254f5e4e32
https://europepmc.org/articles/PMC9487540/
https://europepmc.org/articles/PMC9487540/
Publikováno v:
Journal of Veterinary Medical Science. 82:1700-1703
A single-nucleotide polymorphism causing the replacement of methionine with isoleucine (M121I) in cytochrome b of Babesia gibsoni has been reported to reduce the susceptibility to atovaquone (ATV) in B. gibsoni infection. In our previous study, B. gi
Publikováno v:
The Journal of Veterinary Medical Science
Oxaliplatin (OXL) therapy often causes side effects including chronic peripheral neuropathy. We investigated the pain-relieving effects of recombinant human lactoferrin (rhLf) as well as a long-acting IgG-Fc fused rhLf (rhLf-Fc) on OXL-induced neurop
Autor:
Aiko Iguchi, Mao Mizukami, Takashi Takeuchi, Saori Kobayashi, Naohiro Uchida, Reeko Sato, Masahiro Yamasaki
Publikováno v:
Experimental parasitology. 241
Atovaquone (ATV) has a growth inhibitory effect against Babesia gibsoni. The target site is considered mitochondria, as in the case of Plasmodium spp.; ATV would collapse the mitochondrial membrane potential. B. gibsoni has also reported that single
Autor:
Ikuo Igarashi, Shengwei Ji, Jixu Li, Michihito Tagawa, Masashi Yanagawa, Xuenan Xuan, Eloiza May Galon, Mizuki Tomihari, Aiko Iguchi, Masahito Asada, Mingming Liu, Daisuke Kondoh, Mami Adachi
Publikováno v:
Antimicrob Agents Chemother
Due to drug resistance, commonly used anti-Babesia drugs have limited efficacy against babesiosis and inflict severe side effects. Tafenoquine (TAF) was approved by the U.S. Food and Drug Administration in 2018 for the radical cure of Plasmodium viva